This paper is in the following e-collection/theme issue:

Web-based and Mobile Health Interventions (3094) Innovations and Technology in Cancer Care (400) Patient Education for Cancer (138) Consumer & Patient Education and Shared-Decision Making (636) Health and Risk Communication (43) mHealth in a Clinical Setting (579) Mobile Apps for Cancer Care and Cancer Prevention and Screening (196)

Published on in Vol 23, No 8 (2021): August

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/27824, first published .
Informing Patients With Esophagogastric Cancer About Treatment Outcomes by Using a Web-Based Tool and Training: Development and Evaluation Study

Informing Patients With Esophagogastric Cancer About Treatment Outcomes by Using a Web-Based Tool and Training: Development and Evaluation Study

Informing Patients With Esophagogastric Cancer About Treatment Outcomes by Using a Web-Based Tool and Training: Development and Evaluation Study

Authors of this article:

Loïs F van de Water1, 2 Author Orcid Image ;   Héctor G van den Boorn1 Author Orcid Image ;   Florian Hoxha1 Author Orcid Image ;   Inge Henselmans2 Author Orcid Image ;   Mart M Calff2 Author Orcid Image ;   Mirjam A G Sprangers2 Author Orcid Image ;   Ameen Abu-Hanna3 Author Orcid Image ;   Ellen M A Smets2 Author Orcid Image ;   Hanneke W M van Laarhoven1 Author Orcid Image
Article Authors Cited by (6) Tweetations (4) Metrics

Journals

  1. Derks S, van Laarhoven H. Can we do without chemotherapy? A perspective on the combinations nivolumab-chemotherapy and nivolumab–ipilimumab in metastatic gastric and esophageal cancer. Therapeutic Advances in Medical Oncology 2022;14:175883592211427 View
  2. Kuijper S, Pape M, Haj Mohammad N, van Voorthuizen T, Verhoeven R, van Laarhoven H. SOURCE beyond first‐line: A survival prediction model for patients with metastatic esophagogastric adenocarcinoma after failure of first‐line palliative systemic therapy. International Journal of Cancer 2023;152(6):1202 View
  3. Nik Ab Kadir M, Mohd Hairon S, Yaacob N, Yusof S, Musa K, Yahya M, Mohd Isa S, Mamat Azlan M, Ab Hadi I. myBeST—A Web-Based Survival Prognostic Tool for Women with Breast Cancer in Malaysia: Development Process and Preliminary Validation Study. International Journal of Environmental Research and Public Health 2023;20(4):2985 View
  4. Kuijper S, Pape M, Vissers P, Jeene P, Kouwenhoven E, Haj Mohammad N, Ruurda J, Sosef M, Verhoeven R, van Laarhoven H. Trends in best‐case, typical and worst‐case survival scenarios of patients with non‐metastatic esophagogastric cancer between 2006 and 2020: A population‐based study. International Journal of Cancer 2023;153(1):33 View
  5. Florensa D, Mateo-Fornes J, Lopez Sorribes S, Torres Tuca A, Solsona F, Godoy P. Exploring Cancer Incidence, Risk Factors, and Mortality in the Lleida Region: Interactive, Open-source R Shiny Application for Cancer Data Analysis. JMIR Cancer 2023;9:e44695 View
  6. van de Water L, Kuijper S, Henselmans I, van Alphen E, Kooij E, Calff M, Beerepoot L, Buijsen J, Eshuis W, Geijsen E, Havenith S, Heesakkers F, Mook S, Muller K, Post H, Rütten H, Slingerland M, van Voorthuizen T, van Laarhoven H, Smets E. Effect of a prediction tool and communication skills training on communication of treatment outcomes: a multicenter stepped wedge clinical trial (the SOURCE trial). eClinicalMedicine 2023;64:102244 View